We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA: Enforcement Crackdown Is Moving Quickly
FDA: Enforcement Crackdown Is Moving Quickly
September 8, 2009
The FDA in the last year has employed a broad array of tools — a consent decree, drug seizures and an import alert for 30 generic drug products made at two Ranbaxy facilities in India — to accelerate its stricter enforcement campaign.